Home Cart Sign in  
Chemical Structure| 113712-98-4 Chemical Structure| 113712-98-4

Structure of Tenatoprazole
CAS No.: 113712-98-4

Chemical Structure| 113712-98-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Tenatoprazole is a prodrug of the proton pump inhibitor (PPI) class, which inhibits proton transport with IC50 of 3.2 μM.

Synonyms: TU-199

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Tenatoprazole

CAS No. :113712-98-4
Formula : C16H18N4O3S
M.W : 346.40
SMILES Code : O=S(C1=NC2=C(N1)C=CC(OC)=N2)CC3=NC=C(C(OC)=C3C)C
Synonyms :
TU-199
MDL No. :MFCD00929085
InChI Key :ZBFDAUIVDSSISP-UHFFFAOYSA-N
Pubchem ID :636411

Safety of Tenatoprazole

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P301+P312+P330-P305+P351+P338

Isoform Comparison

Biological Activity

Description
Tenatoprazole (TU-199) is an orally effective imidazopyridine-based proton pump inhibitor noted for its extended plasma half-life. It inhibits hog gastric H+/K+-ATPase activity with an IC50 of 6.2 μM and blocks the interaction between ubiquitin and the ESCRT-1 factor Tsg101, inhibiting the production of several enveloped viruses, including EBV[1].[2].[3].
Target
  • Proton Pump

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00282555 Esophagitis, Reflux Phase 2 Suspended - Canada, Alberta ... More >> Calgary, Alberta, Canada Edmonton, Alberta, Canada Canada, British Columbia Abbottsford, British Columbia, Canada Vancouver, British Columbia, Canada Canada, Manitoba Winnipeg, Manitoba, Canada Canada, Ontario Guelph, Ontario, Canada Hamilton, Ontario, Canada Scarborough, Ontario, Canada Toronto, Ontario, Canada Windsor, Ontario, Canada Canada, Quebec Lévis, Quebec, Canada Montreal, Quebec, Canada Pointe-Claire, Quebec, Canada Sherbrooke, Quebec, Canada St-Charles-de-Borromée, Quebec, Canada Canada, Saskatchewan Saskatoon, Saskatchewan, Canada Canada Quebec, Canada Less <<
NCT00284908 Esophagitis G... More >>astroesophageal Reflux Stomach Ulcer Duodenal Ulcer Less << Phase 1 Completed - United States, Texas ... More >> Healthcare Discoveries, Inc. San Antonio, Texas, United States, 78229 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.89mL

0.58mL

0.29mL

14.43mL

2.89mL

1.44mL

28.87mL

5.77mL

2.89mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories